Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
REVENUES:
TOTAL REVENUES	$ 2,083	$ 0
Costs of sales	1,169	0
GROSS PROFIT	914	0
OPERATING EXPENSES:
Research and development	654	959
Selling, marketing and administrative	18,456	2,636
TOTAL OPERATING EXPENSES	19,110	3,595
OPERATING LOSS	(18,196)	(3,595)
OTHER INCOME (EXPENSE):
Interest income (expense), net	3	(10)
Change in fair value of warrant liability	7,408	(7,935)
TOTAL OTHER INCOME (EXPENSE)	7,411	(7,945)
LOSS BEFORE INCOME TAXES	(10,785)	(11,540)
Income taxes	0	0
NET LOSS	(10,785)	(11,540)
Preferred dividends	0	(322)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$ (10,785)	$ (11,862)
Net loss per common share, basic and diluted (in dollars per share)	$ (0.39)	$ (0.73)
Weighted average shares of common shares, basic and diluted (in shares)	27,539,229	16,361,583
Product [Member]
REVENUES:
TOTAL REVENUES	$ 2,083	$ 0